{"address1": "5857 Owens Avenue", "address2": "Suite 300", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "760 452 8111", "website": "https://www.qlgntx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael S. Poirier", "age": 68, "title": "Chief Operating Officer", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 632698, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin A. Richardson II", "age": 56, "title": "Interim CEO, Interim CFO & Chairman of the Board", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert W. Campbell Becher", "age": 53, "title": "President & Director", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher L. Lotz", "age": 59, "title": "VP of Finance & Corporate Secretary", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 578555, "exercisedValue": 0, "unexercisedValue": 60608}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.64, "open": 3.62, "dayLow": 3.21, "dayHigh": 3.7799, "regularMarketPreviousClose": 3.64, "regularMarketOpen": 3.62, "regularMarketDayLow": 3.21, "regularMarketDayHigh": 3.7799, "payoutRatio": 0.0, "beta": 0.109, "trailingPE": 0.00096011005, "forwardPE": -3.49, "volume": 950254, "regularMarketVolume": 950254, "averageVolume": 79200, "averageVolume10days": 215690, "averageDailyVolume10Day": 215690, "bid": 3.46, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 2570144, "fiftyTwoWeekLow": 2.96, "fiftyTwoWeekHigh": 29.45, "fiftyDayAverage": 3.3915, "twoHundredDayAverage": 6.729835, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3616223, "profitMargins": 0.0, "floatShares": 735989, "sharesOutstanding": 736431, "sharesShort": 70049, "sharesShortPriorMonth": 88939, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0951, "heldPercentInsiders": 0.03767, "heldPercentInstitutions": 0.01467, "shortRatio": 6.82, "shortPercentOfFloat": 0.0952, "impliedSharesOutstanding": 736431, "bookValue": -3.905, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -7858534, "trailingEps": 3635.0, "forwardEps": -1.0, "lastSplitFactor": "1:50", "lastSplitDate": 1730764800, "enterpriseToEbitda": -0.525, "52WeekChange": -0.8338095, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 3.49, "recommendationKey": "none", "totalCash": 388152, "totalCashPerShare": 0.527, "ebitda": -6886340, "totalDebt": 1434231, "quickRatio": 0.379, "currentRatio": 0.519, "returnOnAssets": -1.26388, "grossProfits": -2553290, "freeCashflow": -6566239, "operatingCashflow": -9729566, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QLGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Qualigen Therapeutics, Inc.", "corporateActions": [], "preMarketTime": 1743596951, "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_1436301", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 0.09850001, "fiftyDayAverageChangePercent": 0.0290432, "twoHundredDayAverageChange": -3.239835, "twoHundredDayAverageChangePercent": -0.48141372, "priceToBook": -0.893726, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1435066200000, "preMarketChange": -0.28929996, "preMarketChangePercent": -8.289397, "preMarketPrice": 3.2007, "regularMarketChange": -0.1500001, "regularMarketDayRange": "3.21 - 3.7799", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 79200, "fiftyTwoWeekLowChange": 0.53, "fiftyTwoWeekLowChangePercent": 0.17905404, "fiftyTwoWeekRange": "2.96 - 29.45", "fiftyTwoWeekHighChange": -25.960001, "fiftyTwoWeekHighChangePercent": -0.88149405, "fiftyTwoWeekChangePercent": -83.38095, "dividendDate": 1590451200, "earningsTimestampStart": 1743710400, "earningsTimestampEnd": 1744056000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 3635.0, "epsForward": -1.0, "longName": "Qualigen Therapeutics, Inc.", "regularMarketChangePercent": -4.1208816, "regularMarketPrice": 3.49, "displayName": "Qualigen Therapeutics", "trailingPegRatio": null}